|Bid||43.16 x 1000|
|Ask||44.79 x 900|
|Day's range||42.50 - 44.32|
|52-week range||35.33 - 63.46|
|Beta (5Y monthly)||1.22|
|PE ratio (TTM)||N/A|
|Earnings date||03 May 2023 - 08 May 2023|
|Forward dividend & yield||1.80 (4.09%)|
|Ex-dividend date||31 Mar 2023|
|1y target est||53.12|
CHICAGO, March 31, 2023--Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") today announced that it intends to take ownership of the collateral that supports its approximately $486 million cash-pay mezzanine loan to Santerre Health Investors (the "Santerre Mezzanine Loan"). The Santerre Mezzanine Loan is secured by equity interests in entities that collectively own a diverse pool of medical office buildings, senior housing operating portfolio communities, triple-net leased skilled nursing faci
CHICAGO, March 14, 2023--Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") today announced that its Board of Directors has declared a quarterly dividend of $0.45 per common share. The dividend will be payable in cash on April 13, 2023 to stockholders of record as of the close of business on April 3, 2023.
Healthpeak's (PEAK) focus on enhancing its life-science real-estate assets, capital-recycling moves and a solid balance sheet bodes well. Stiff competition from peers and rising interest rates are woes.